Research Topic · Peer-Reviewed

Gastrointestinal Cancer Immunotherapy

Gastrointestinal cancer immunotherapy is a type of cancer treatment that uses a person’s own immune system to fight the cancer. The immune system is made up of special cells and proteins that attack and destroy anything that it recognizes as dangerous, such as bacteria and viruses. Immunotherapy harnesses the power …

📚 0 peer-reviewed articles cited 🔖 ISSN 2471-7061 🗓 Reviewed June 2026

Overview

Gastrointestinal cancer immunotherapy is a type of cancer treatment that uses a person’s own immune system to fight the cancer. The immune system is made up of special cells and proteins that attack and destroy anything that it recognizes as dangerous, such as bacteria and viruses. Immunotherapy harnesses the power of the immune system to seek out and destroy cancer cells, while avoiding healthy cells. This form of cancer treatment can be used alone or in combination with other forms of treatment, such as surgery, radiation and chemotherapy. By stimulating the body's own immune response, immunotherapy can be effective in treating a range of gastrointestinal cancers, including colorectal, pancreatic, and gastric cancer. Gastrointestinal cancer immunotherapy is becoming an increasingly popular therapy option, as it can offer improved outcomes and reduce side effects when compared to more traditional treatments.

Research published in this journal

No peer-reviewed research on this exact topic has been published in Colon And Rectal Cancer yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Colon And Rectal Cancer (ISSN 2471-7061).

Journal editorial board
Frank A. Frizelle · New Zealand Gennaro Galizia · Italy Tamotsu Tsukahara · Japan

This page summarises published research for orientation; it is not medical or professional advice.